Resistance of bacteriophage PBS2 infection to rifampicin, an inhibitor of Bacillus subtilis RNA synthesis.
D001412:Bacillus subtilis / Q000187:drug effects; D001435:Bacteriophages / Q000187:drug effects*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D003609:Dactinomycin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D007700:Kinetics; D008154:Lucanthone / Q000494:pharmacology; D012367:RNA, Viral / Q000032:analysis / Q000096:biosynthesis*; D012293:Rifampin / Q000494:pharmacology*; D013310:Streptovaricin / Q000494:pharmacology; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects
D012367:RNA, Viral; D014316:Tritium; D013310:Streptovaricin; D003609:Dactinomycin; D004254:DNA Nucleotidyltransferases; D008154:Lucanthone; D012293:Rifampin; D014529:Uridine